Jayne Prats

3.4k total citations
65 papers, 1.3k citations indexed

About

Jayne Prats is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Jayne Prats has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cardiology and Cardiovascular Medicine, 43 papers in Surgery and 13 papers in Internal Medicine. Recurrent topics in Jayne Prats's work include Antiplatelet Therapy and Cardiovascular Diseases (50 papers), Acute Myocardial Infarction Research (43 papers) and Coronary Interventions and Diagnostics (31 papers). Jayne Prats is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (50 papers), Acute Myocardial Infarction Research (43 papers) and Coronary Interventions and Diagnostics (31 papers). Jayne Prats collaborates with scholars based in United States, France and United Kingdom. Jayne Prats's co-authors include Efthymios Deliargyris, Matthew J. Price, Gregg W. Stone, Deepak L. Bhatt, Robert A. Harrington, Dominick J. Angiolillo, Philippe Gabríel Steg, Tiepu Liu, Kenneth W. Mahaffey and Christian W. Hamm and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Jayne Prats

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayne Prats United States 18 1.1k 735 298 74 65 65 1.3k
Zuzana Moťovská Czechia 16 1.1k 0.9× 606 0.8× 199 0.7× 48 0.6× 109 1.7× 89 1.3k
Petr Widimský Czechia 17 1.2k 1.1× 560 0.8× 231 0.8× 74 1.0× 220 3.4× 36 1.3k
Jan A.S. Van der Heyden Netherlands 14 988 0.9× 473 0.6× 226 0.8× 92 1.2× 104 1.6× 30 1.1k
Martin M. Zenni United States 20 1.3k 1.2× 749 1.0× 369 1.2× 77 1.0× 158 2.4× 41 1.5k
Kelly Maresh United States 11 927 0.8× 641 0.9× 305 1.0× 91 1.2× 134 2.1× 16 1.0k
Salvatore Colangelo Italy 11 540 0.5× 385 0.5× 110 0.4× 64 0.9× 92 1.4× 21 631
Drew A. Purdy United States 3 1.3k 1.1× 661 0.9× 411 1.4× 38 0.5× 63 1.0× 4 1.4k
Ioanna Xanthopoulou Greece 23 1.7k 1.5× 987 1.3× 453 1.5× 260 3.5× 81 1.2× 77 2.0k
Willem J.M. Dewilde Netherlands 9 1.6k 1.4× 488 0.7× 456 1.5× 52 0.7× 102 1.6× 19 1.7k
Christine Zürn Germany 10 772 0.7× 387 0.5× 144 0.5× 238 3.2× 112 1.7× 18 1.0k

Countries citing papers authored by Jayne Prats

Since Specialization
Citations

This map shows the geographic impact of Jayne Prats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayne Prats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayne Prats more than expected).

Fields of papers citing papers by Jayne Prats

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayne Prats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayne Prats. The network helps show where Jayne Prats may publish in the future.

Co-authorship network of co-authors of Jayne Prats

This figure shows the co-authorship network connecting the top 25 collaborators of Jayne Prats. A scholar is included among the top collaborators of Jayne Prats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayne Prats. Jayne Prats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, David J., et al.. (2021). Influence of Lipid Excipients on Platelet Function and the Pharmacodynamic Effects of Aspirin. Journal of Cardiovascular Pharmacology. 78(2). 297–301. 3 indexed citations
2.
Bhatt, Deepak L., Dominick J. Angiolillo, Philippe Gabríel Steg, et al.. (2020). IMPACT OF WEIGHT ON THE ANTIPLATELET EFFECTS OF ASPIRIN-RESULTS OF A POOLED ANALYSIS OF TWO RANDOMIZED CROSSOVER STUDIES COMPARING A LIQUID ASPIRIN FORMULATION WITH ENTERIC COATED ASPIRIN. Journal of the American College of Cardiology. 75(11). 1344–1344.
3.
Angiolillo, Dominick J., Deepak L. Bhatt, Frank L. Lanza, et al.. (2020). Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation. Journal of Thrombosis and Thrombolysis. 49(3). 337–343. 13 indexed citations
4.
Prats, Jayne, et al.. (2018). A Novel Bridging Strategy for Patients Undergoing Emergent Non-Cardiac Surgery with a Recent Coronary Stent. Cardiology and Therapy. 7(2). 209–213. 2 indexed citations
5.
6.
Vaduganathan, Muthiah, Robert A. Harrington, Gregg W. Stone, et al.. (2017). Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX). The American Journal of Cardiology. 120(7). 1043–1048. 11 indexed citations
7.
Giustino, Gennaro, Roxana Mehran, George Dangas, et al.. (2017). Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI. Journal of the American College of Cardiology. 70(15). 1846–1857. 46 indexed citations
8.
Cavender, Matthew A., Robert A. Harrington, Gregg W. Stone, et al.. (2017). ISCHEMIC EVENTS OCCUR EARLY IN PATIENTS UNDERGOING PCI AND ARE REDUCED WITH CANGRELOR: FINDINGS FROM CHAMPION PHOENIX. Journal of the American College of Cardiology. 69(11). 25–25. 3 indexed citations
9.
Chen, Jianchun, Denise Evans, Jayne Prats, et al.. (2017). P2Y12 Receptor Function and Response to Cangrelor in Neonates With Cyanotic Congenital Heart Disease. JACC Basic to Translational Science. 2(4). 465–476. 11 indexed citations
10.
Giustino, Gennaro, Roxana Mehran, Sameer Bansilal, et al.. (2016). Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials. The American Journal of Cardiology. 118(1). 6–16. 6 indexed citations
11.
Cavender, Matthew A., Deepak L. Bhatt, Gregg W. Stone, et al.. (2015). CANGRELOR IN ELDERLY PATIENTS UNDERGOING PCI: FINDINGS FROM CHAMPION-PHOENIX. Journal of the American College of Cardiology. 65(10). A1773–A1773. 3 indexed citations
12.
Angiolillo, Dominick J., Deepak L. Bhatt, Gregg W. Stone, et al.. (2015). IMPACT OF CANGRELOR OVERDOSING ON BLEEDING COMPLICATIONS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CHAMPION TRIALS. Journal of the American College of Cardiology. 65(10). A1905–A1905. 9 indexed citations
13.
Angiolillo, Dominick J., Deepak L. Bhatt, Philippe Gabríel Steg, et al.. (2015). Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials. Journal of Thrombosis and Thrombolysis. 40(3). 317–322. 24 indexed citations
14.
Clemmensen, Peter, Arnoud W.J. van ‘t Hof, Efthymios Deliargyris, et al.. (2014). PREDICTORS ASSOCIATED WITH ACUTE STENT THROMBOSIS AFTER PRIMARY PCI: THE EUROMAX TRIAL. Journal of the American College of Cardiology. 63(12). A27–A27. 7 indexed citations
15.
Stone, Gregg W., Tim Clayton, Efthymios Deliargyris, et al.. (2013). Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding. Journal of the American College of Cardiology. 63(1). 15–20. 49 indexed citations
16.
Généreux, Philippe, Gregg W. Stone, Robert A. Harrington, et al.. (2013). Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 63(7). 619–629. 76 indexed citations
17.
Stone, Gregg W., et al.. (2012). TCT-52 Bivalirudin reduces cardiac mortality in patients with and without major bleeding: The HORIZONS-AMI trial. Journal of the American College of Cardiology. 60(17). B16–B16. 1 indexed citations
18.
Buszman, Piotr, Wojciech Wojakowski, Krzysztof Milewski, et al.. (2011). Controlled Reperfusion with Intravenous Bivalirudin and Intracoronary Abciximab Combination Therapy in the Porcine Myocardial Infarction Model. Thrombosis Research. 130(2). 265–272. 13 indexed citations
19.
Zucker, Márcia L., et al.. (2005). Sensitivity of a Modified ACT Test to Levels of Bivalirudin Used During Cardiac Surgery. Journal of ExtraCorporeal Technology. 37(4). 364–368. 28 indexed citations
20.
Farthing, Don, Terri Larus, Itaf Fakhry, et al.. (2004). Liquid chromatography method for determination of bivalirudin in human plasma and urine using automated ortho-phthalaldehyde derivatization and fluorescence detection. Journal of Chromatography B. 802(2). 355–359. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zuzana Moťovská Breakdown of academic impact, for papers by Petr Widimský Breakdown of academic impact, for papers by Jan A.S. Van der Heyden Breakdown of academic impact, for papers by Martin M. Zenni Breakdown of academic impact, for papers by Kelly Maresh Breakdown of academic impact, for papers by Salvatore Colangelo Breakdown of academic impact, for papers by Drew A. Purdy Breakdown of academic impact, for papers by Ioanna Xanthopoulou Breakdown of academic impact, for papers by Willem J.M. Dewilde Breakdown of academic impact, for papers by Christine Zürn
Rankless by CCL
2026